CTVA
Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Insiders: neutral. Moteurs : Congrès, fondamentaux. Initiés : neutre.
Research, not advice.
À propos
Corteva, Inc.
- Nom
- Corteva, Inc.
- Secteur
- Basic Materials
- Industrie
- Agricultural Inputs
- Bourse
- NYSE
- Capitalisation
- $8.0B
- Employés
- 21,500
- PDG
- Luke C. Kissam
- Site web
- https://www.corteva.com
- Marché
- AVDBIOXCTA-PACTA-PBFMCNTR
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Decouvert par les declarations du Congres
- Insiders
- —
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
—
Avg sell (VWAP, 90d window) —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- —
- Last synced
-
2026-10-06 10:56:08
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
No Form 4 filings for this company in this window.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2024-09-04 | John James | Sale (Full) | $1,001 - $15,000 |
| 2024-02-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-11-10 | John James | Purchase | $1,001 - $15,000 |
| 2023-11-03 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-10-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-08-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-08-03 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-07-28 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-06-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-06-26 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-05-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-05-19 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-04-10 | Debbie Dingell | Purchase | $15,001 - $50,000 |
| 2023-01-09 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-11-03 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-08-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-02-17 | John Henry Rutherford | Sale (Full) | $1,001 - $15,000 |
| 2022-01-11 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2021-02-12 | Mary Gay Scanlon | Sale (Full) | $1,001 - $15,000 |
| 2021-01-21 | John Henry Rutherford | Sale (Full) | $1,001 - $15,000 |
| 2020-03-18 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2019-12-06 | Gilbert Ray Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 2019-09-11 | Dean Phillips | Sale (Full) | $1,001 - $15,000 |
| 2019-08-23 | Thomas Suozzi | Sale (Full) | $1,001 - $15,000 |
| 2019-08-21 | Thomas Suozzi | Sale (Full) | $1,001 - $15,000 |
| 2019-08-14 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2019-08-13 | Dean Phillips | Purchase | $1,001 - $15,000 |
| 2019-08-06 | K. Michael Conaway | Sale (Full) | $1,001 - $15,000 |
| 2019-06-03 | Gilbert Ray Cisneros | Exchange | $1,001 - $15,000 |
| 2019-05-31 | Debbie Dingell | Exchange | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Insiders: neutral. Moteurs : Congrès, fondamentaux. Initiés : neutre.
CTVA shows genuine fundamental improvement in 2025 with solid margins and cash flow, but the near-absence of a catalytic signal (score: 15) severely limits the event-driven upside case.
The first sentence of the analysis written for CTVA on 2026-10-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Unavailable or mixed. No open-market purchase or sale value stored
- Congress Unavailable or mixed. 1 purchase disclosure year to date, a thin reading
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 1.43 · operating margin 15%
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 47.3% | 43.6% | 42.4% | 40.2% | 41.1% | |
| Ebit Margin | 10.7% | 8.9% | 7.7% | 8.6% | 15.2% | |
| Ebitda Margin | 17.6% | 16.2% | 14.7% | 15.6% | 23.1% | |
| Operating Profit Margin | 15.1% | 12.4% | 12.2% | 11.0% | 8.4% | |
| Pretax Profit Margin | 9.7% | 7.5% | 6.3% | 8.2% | 15.0% | |
| Continuous Operations Profit Margin | 6.9% | 5.1% | 5.5% | 7.0% | 11.6% | |
| Net Profit Margin | 6.3% | 5.4% | 4.3% | 6.6% | 11.2% | |
| Bottom Line Profit Margin | 6.3% | 5.4% | 4.3% | 6.6% | 11.2% | |
| Current Ratio | 1.430 | 1.454 | 1.562 | 1.563 | 1.626 | |
| Quick Ratio | 0.962 | 0.931 | 0.899 | 0.929 | 1.085 | |
| Solvency Ratio | 0.124 | 0.127 | 0.110 | 0.139 | 0.180 | |
| Cash Ratio | 0.373 | 0.299 | 0.254 | 0.297 | 0.467 | |
| Price To Earnings Ratio | 41.894 | 43.481 | 46.077 | 36.969 | 19.782 | |
| Price To Earnings Growth Ratio | 1.892 | 1.675 | -1.332 | -1.104 | 0.122 | |
| Forward Price To Earnings Growth Ratio | 1.892 | 1.675 | -1.332 | -1.104 | 0.122 | |
| Price To Earnings Diluted Ratio | 41.894 | 43.815 | 46.524 | 37.203 | 19.949 | |
| Price To Earnings Diluted Growth Ratio | 1.815 | 1.671 | -1.337 | -1.116 | 0.124 | |
| Price To Book Ratio | 1.888 | 1.661 | 1.357 | 1.675 | 1.371 | |
| Price To Sales Ratio | 2.619 | 2.337 | 1.972 | 2.427 | 2.223 | |
| Price To Free Cash Flow Ratio | 16.192 | 25.525 | 28.940 | 158.684 | 16.153 | |
| Price To Operating Cash Flow Ratio | 13.382 | 18.421 | 19.206 | 48.588 | 12.759 | |
| Debt To Assets Ratio | 0.060 | 0.066 | 0.058 | 0.031 | 0.026 | |
| Debt To Equity Ratio | 0.107 | 0.114 | 0.099 | 0.052 | 0.044 | |
| Debt To Capital Ratio | 0.097 | 0.102 | 0.090 | 0.049 | 0.042 | |
| Long Term Debt To Capital Ratio | 0.065 | 0.076 | 0.084 | 0.048 | 0.042 | |
| Financial Leverage Ratio | 1.775 | 1.716 | 1.717 | 1.684 | 1.668 | |
| Working Capital Turnover Ratio | 3.508 | 3.202 | 2.895 | 2.900 | 2.565 | |
| Operating Cash Flow Ratio | 0.281 | 0.207 | 0.170 | 0.081 | 0.285 | |
| Operating Cash Flow Sales Ratio | 0.196 | 0.127 | 0.103 | 0.050 | 0.174 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.826 | 0.722 | 0.664 | 0.306 | 0.790 | |
| Debt Service Coverage Ratio | 2.409 | 2.363 | 5.547 | 24.686 | 65.851 | |
| Interest Coverage Ratio | 14.550 | 8.996 | 9.056 | 24.405 | 43.900 | |
| Short Term Operating Cash Flow Coverage Ratio | 3.810 | 2.860 | 8.980 | 37.913 | 160.412 | |
| Operating Cash Flow Coverage Ratio | 1.320 | 0.794 | 0.711 | 0.667 | 2.435 | |
| Capital Expenditure Coverage Ratio | 5.763 | 3.593 | 2.973 | 1.441 | 4.759 | |
| Dividend Paid And Capex Coverage Ratio | 3.195 | 2.033 | 1.711 | 0.852 | 2.811 | |
| Dividend Payout Ratio | 0.434 | 0.505 | 0.597 | 0.364 | 0.226 | |
| Enterprise Value Multiple | 14.210 | 14.300 | 13.331 | 14.840 | 8.691 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 47.3% | ▲3.6% | ▲4.4% |
| Ebit Margin | 10.7% | ▲1.8% | ▲0.5% |
| Ebitda Margin | 17.6% | ▲1.5% | ▲0.2% |
| Operating Profit Margin | 15.0% | ▲2.6% | ▲3.2% |
| Pretax Profit Margin | 9.7% | ▲2.2% | ▲0.4% |
| Continuous Operations Profit Margin | 6.9% | ▲1.8% | ▼-0.3% |
| Net Profit Margin | 6.3% | ▲0.9% | ▼-0.5% |
| Bottom Line Profit Margin | 6.3% | ▲0.9% | ▼-0.5% |
| Current Ratio | 1.430 | ▼-0.024 | ▼-0.097 |
| Quick Ratio | 0.962 | ▲0.032 | ▲0.001 |
| Solvency Ratio | 0.124 | ▼-0.003 | ▼-0.011 |
| Cash Ratio | 0.373 | ▲0.074 | ▲0.035 |
| Price To Earnings Ratio | 41.894 | ▼-1.587 | ▲4.253 |
| Price To Earnings Growth Ratio | 1.892 | ▲0.218 | ▲1.642 |
| Forward Price To Earnings Growth Ratio | 1.892 | ▲0.218 | ▲1.642 |
| Price To Earnings Diluted Ratio | 41.894 | ▼-1.922 | ▲4.017 |
| Price To Earnings Diluted Growth Ratio | 1.815 | ▲0.144 | ▲1.584 |
| Price To Book Ratio | 1.888 | ▲0.227 | ▲0.298 |
| Price To Sales Ratio | 2.619 | ▲0.282 | ▲0.304 |
| Price To Free Cash Flow Ratio | 16.192 | ▼-9.333 | ▼-32.907 |
| Price To Operating Cash Flow Ratio | 13.382 | ▼-5.039 | ▼-9.089 |
| Debt To Assets Ratio | 0.060 | ▼-0.006 | ▲0.012 |
| Debt To Equity Ratio | 0.107 | ▼-0.007 | ▲0.024 |
| Debt To Capital Ratio | 0.097 | ▼-0.005 | ▲0.021 |
| Long Term Debt To Capital Ratio | 0.065 | ▼-0.011 | ▲0.002 |
| Financial Leverage Ratio | 1.775 | ▲0.058 | ▲0.062 |
| Working Capital Turnover Ratio | 3.508 | ▲0.306 | ▲0.494 |
| Operating Cash Flow Ratio | 0.281 | ▲0.074 | ▲0.076 |
| Operating Cash Flow Sales Ratio | 0.196 | ▲0.069 | ▲0.066 |
| Free Cash Flow Operating Cash Flow Ratio | 0.827 | ▲0.105 | ▲0.165 |
| Debt Service Coverage Ratio | 2.409 | ▲0.046 | ▼-17.762 |
| Interest Coverage Ratio | 14.550 | ▲5.554 | ▼-5.631 |
| Short Term Operating Cash Flow Coverage Ratio | 3.810 | ▲0.950 | ▼-38.985 |
| Operating Cash Flow Coverage Ratio | 1.320 | ▲0.527 | ▲0.135 |
| Capital Expenditure Coverage Ratio | 5.763 | ▲2.170 | ▲2.057 |
| Dividend Paid And Capex Coverage Ratio | 3.195 | ▲1.162 | ▲1.075 |
| Dividend Payout Ratio | 0.434 | ▼-0.071 | ▲0.009 |
| Enterprise Value Multiple | 14.210 | ▼-0.090 | ▲1.136 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $45.58B | $39.51B | $33.98B | $42.37B | $34.79B | |
| Enterprise value | $43.64B | $39.11B | $33.82B | $40.48B | $31.45B | |
| EV / Sales | 2.51x | 2.31x | 1.96x | 2.32x | 2.01x | |
| EV / Op. cash flow | 12.81x | 18.23x | 19.12x | 46.43x | 11.53x | |
| EV / Free cash flow | 15.50x | 25.27x | 28.81x | 151.63x | 14.60x | |
| EV / EBITDA | 14.21x | 14.30x | 13.33x | 14.84x | 8.69x | |
| Net debt / EBITDA | -0.63x | -0.15x | -0.06x | -0.69x | -0.92x | |
| Current ratio | 1.43x | 1.45x | 1.56x | 1.56x | 1.63x | |
| Income quality | 3.08x | 2.49x | 1.88x | 0.72x | 1.50x | |
| Graham number | $36 | $32 | $29 | $35 | $43 | |
| Graham net-net | -$9 | -$10 | -$10 | -$8 | -$8 | |
| Tax burden | 64.8% | 71.1% | 67.2% | 80.4% | 75.0% | |
| Interest burden | 90.4% | 84.5% | 82.4% | 94.8% | 98.7% | |
| Working capital | $5.21B | $4.71B | $5.85B | $6.05B | $5.99B | |
| Invested capital | $28.20B | $28.09B | $30.37B | $29.61B | $30.47B | |
| Return on assets | 2.6% | 2.2% | 1.7% | 2.7% | 4.2% | |
| Operating ROA | 6.3% | 5.0% | 4.9% | 4.5% | 3.1% | |
| Return on tangible assets | 4.5% | 4.2% | 3.2% | 4.9% | 7.9% | |
| Return on equity | 4.5% | 3.8% | 2.9% | 4.5% | 6.9% | |
| Return on invested capital | 5.9% | 4.5% | 5.5% | 5.2% | 3.1% | |
| Return on capital employed | 8.5% | 6.9% | 6.5% | 6.0% | 4.0% | |
| Earnings yield | 2.4% | 2.3% | 2.2% | 2.7% | 5.1% | |
| Free cash flow yield | 6.2% | 3.9% | 3.5% | 0.6% | 6.2% | |
| Capex / Op. cash flow | 17.4% | 27.8% | 33.6% | 69.4% | 21.0% | |
| Capex / Depreciation | 49.1% | 48.7% | 49.1% | 49.5% | 46.1% | |
| Capex / Sales | 3.4% | 3.5% | 3.5% | 3.5% | 3.7% | |
| SG&A / Sales | 20.1% | 18.9% | 18.4% | 18.2% | 20.5% | |
| R&D / Sales | 8.5% | 8.3% | 7.8% | 7.0% | 7.6% | |
| Stock comp / Sales | 0.0% | 0.0% | 0.0% | 0.3% | 0.0% | |
| Intangibles / Total assets | 43.8% | 47.2% | 47.1% | 45.3% | 47.6% | |
| Days sales outstanding | 134d | 123d | 116d | 119d | 112d | |
| Days payables outstanding | 175d | 155d | 157d | 171d | 163d | |
| Operating cycle | 359d | 331d | 370d | 357d | 317d | |
| Cash conversion cycle | 184d | 176d | 213d | 186d | 154d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-10-05 Is Corteva Inc (CTVA) Overvalued After 3.9% Rally? GF Value Says Overvalued On October 05, 2026, Corteva Inc (CTVA) shares rose 3.9% today, currently trading at $12.39. The stock has experienced a 52-week range between $9.08 and $14.44,
- 2026-10-05 Corteva remains a ''buy'' as innovation offsets pressure on legacy products, BofA says Bank of America (BofA) keeps its ''buy'' rating on Corteva Inc (NYSE:CTVA) and sets an $18 price target, citing new product launches and tighter 2027 agriculture markets. Corteva, the US crop protection company, became a focused crop protection business on October 1, after separating its seed business into Vylor.
- 2026-10-02 Corteva Just Split in Two. Here''s What Shareholders Own Now Corteva shareholders woke up to what looked like an 83% crash, but the real story is what they now own across two tickers and a lawsuit that could unwind the entire split.
- 2026-10-01 Vylor Added to the S&P 500; Twilio Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600: Vylor Inc. (NYSE: VYLR) was added to
- 2026-10-01 US states filed fraud lawsuit over Corteva''s Vylor spinoff A group of US states sued Corteva and Vylor on Thursday, alleging Corteva''s spinoff of its seed business to Vylor was a fraudulent attempt to avoid tens of billions in legacy liabilities related to "forever chemicals" polluting the environment.
- 2026-10-01 What''s happening with Corteva stock price today? Corteva (CTVA) shares are undergoing a massive price adjustment on October 1st, plunging rather sharply after the market opened. While a glance at CTVA stock might look alarming, the crash isn''t because of a sudden operational collapse or unexpected earnings miss.
- 2026-10-01 Stock Market Midday, Oct. 1: Stocks Edge Lower as Treasury Yields Surge to 24-Year High Bond yields hit their highest level in two decades, pressuring blue chip dividend stocks and weighing on the broader market, today, Oct. 1, 2026.
- 2026-10-01 Corteva Stock Isn''t Really down 80% Corteva, a farming input maker, is now two companies, Corteva and Vylor. Corteva sells crop protection chemicals.
- 2026-10-01 Corteva Begins New Chapter as Focused, Innovation-Led, Global Crop Protection Leader Company completes spin-off of seed business, well positioned to advance its robust pipeline with 12 new actives, including 5 biologicals, for launch in the next decade INDIANAPOLIS, Oct. 1, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it has successfully spun off its advanced seed and genetics business and will move forward as a leading, pure-play global crop protection company. "This is a new day for Corteva, and we couldn''t be more excited as we move forward with greater focus, agility and a renewed commitment to innovation and operational excellence," said Corteva CEO Luke Kissam.
- 2026-10-01 Corteva Announces Expiration and Final Results of Private Exchange Offers and Consent Solicitations for EIDP''s 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033 INDIANAPOLIS, Oct. 1, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announced today that Vylor Inc., a Delaware corporation and its wholly owned subsidiary ("Vylor"), has received the final results of its previously announced (i) private offers to exchange (with respect to each series, an "Exchange Offer" and together, the "Exchange Offers") any and all of the outstanding senior notes of the series listed in the table below issued by EIDP, Inc., a Delaware corporation and a wholly owned subsidiary of Corteva ("EIDP" and such notes, collectively, the "EIDP Notes"), to the extent held by eligible holders, for a corresponding series of notes to be newly issued by Vylor (collectively, the "Vylor Notes") and (ii) related consent solicitations (the "Consent Solicitations") made by Vylor on behalf of EIDP to adopt certain proposed amendments to the indentures governing the EIDP Notes. The Exchange Offers and Consent Solicitations expired at 5:00 p.m.